NCT05639231: INTOMOB

An INtervention TO Improve MOBility of Older Hospitalized Patients

Completed NA Last updated 12 August 2025

What this trial tests

NA trial testing INTOMOB intervention in Hospital Mobility in 383 participants. Completed in 18 July 2025.

Timeline

15 December 2022

Primary endpoint
18 July 2025

18 July 2025

Quick facts

Lead sponsor	Insel Gruppe AG, University Hospital Bern
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	383
Start date	15 December 2022
Primary completion	18 July 2025
Estimated completion	18 July 2025
Sites	4 locations across Switzerland

Drugs / interventions tested

• INTOMOB intervention

Conditions studied

• Hospital Mobility — all drugs for Hospital Mobility →
• Mobility Limitation — all drugs for Mobility Limitation →
• Life-Space — all drugs for Life-Space →
• Functional Status — all drugs for Functional Status →

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

60 and older, any sex, with Hospital Mobility or Mobility Limitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low mobility during an acute care hospitalization is very frequent, particularly among older patients, and associated with adverse outcomes, such as persistent functional decline, institutionalization and death. However, increasing hospital mobility remains challenging because of the multiple existing barriers.

The goal of this clinical trial is to test the effect of a multilevel intervention to increase hospital mobility, which addresses modifiable barriers and facilitators and does not require unavailable additional resources.

This study aims to answer whether this intervention can improve mobility and patient-relevant outcomes such as life-space mobility and functional status.

The multilevel intervention will target:

1. The patients, who will receive an information booklet, a customizable diary, an exercise booklet and an iPad with access to the videos of the exercise booklet.
2. The healthcare professionals (nursing staff and physicians) who will complete an e-learning, receive an oral presentation on the intervention, and receive a "mobility checklist" that reminds them of what they should assess daily regarding mobility.
3. The hospital environment, where posters will be hung in the wards, including walking itineraries, on topics of interest to older adults.

In a first phase, the intervention will be pilot-tested in one ward of each hospital. The intervention will then be adapted based on patient and healthcare professional feedback.

In a second phase, the intervention will be tested in a cluster randomized controlled trial, and compared to standard of care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Feasibility and Acceptability of an INtervention TO Increase MOBility in Older Hospitalized Medical Patients (INTOMOB): A Mixed-Methods Pilot Study.
   Bergsma D, Panait C, Leist P, Mooser B, et al · · 2023 · cited 3× · PMID 37790194 · DOI 10.1177/23337214231202148
2. Impact of an INtervention to increase MOBility in older hospitalized medical patients (INTOMOB): Study protocol for a cluster randomized controlled trial.
   Mooser B, Bergsma D, Liechti FD, Baumgartner C, et al · · 2023 · cited 1× · PMID 37907858 · DOI 10.1186/s12877-023-04285-3